Alaunos Therapeutics TCRT Stock
$2.62
-4.727277%
Add to favorites
SECTOR
INDUSTRY
COUNTRY
Exchange
Market Cap
$6.40M
LOW - HIGH [24H]
$2.61
-
$2.78
VOLUME [24H]
$8.01K
P/E Ratio
0
Earnings per share
-$2.12
ISIN
US98973P3091
Alaunos Therapeutics Price Chart
Alaunos Therapeutics TCRT Financial and Trading Overview
| Alaunos Therapeutics stock price | 2.62 USD |
| Previous Close | 2.85 USD |
| Open | 2.95 USD |
| Bid | 2.39 USD x 100 |
| Ask | 3.28 USD x 100 |
| Day's Range | 2.75 - 3.04 USD |
| 52 Week Range | 1.67 - 6.2 USD |
| Volume | 10.73K USD |
| Avg. Volume | 15.82K USD |
| Market Cap | 7.01M USD |
| Beta (5Y Monthly) | -1.126 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.12 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
TCRT Valuation Measures
| Enterprise Value | 6.6M USD |
| Trailing P/E | N/A |
| Forward P/E | -4.783333 |
| PEG Ratio (5 yr expected) | 0.58 |
| Price/Sales (ttm) | 2336.3193 |
| Price/Book (mrq) | 2.2580643 |
| Enterprise Value/Revenue | 2199.186 |
| Enterprise Value/EBITDA | -1.597 |
Trading Information
Alaunos Therapeutics Stock Price History
| Beta (5Y Monthly) | -1.126 |
| 52-Week Change | 2.86% |
| S&P500 52-Week Change | 27.29% |
| 52 Week High | 6.2 USD |
| 52 Week Low | 1.67 USD |
| 50-Day Moving Average | 2.76 USD |
| 200-Day Moving Average | 2.89 USD |
TCRT Share Statistics
| Avg. Volume (3 month) | 15.82K USD |
| Avg. Daily Volume (10-Days) | 22.77K USD |
| Shares Outstanding | 2.44M |
| Float | 1.91M |
| Short Ratio | 0.7 |
| % Held by Insiders | 14.02% |
| % Held by Institutions | 6.52% |
| Shares Short | 7.89K |
| Short % of Float | 0.34% |
| Short % of Shares Outstanding | 0.32% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -138166.67% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -129.43% |
| Return on Equity (ttm) | -350.29% |
Income Statement
| Revenue (ttm) | 3K USD |
| Revenue Per Share (ttm) | 0.001 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -1440000 USD |
| EBITDA | -4130500 USD |
| Net Income Avi to Common (ttm) | -4215000 USD |
| Diluted EPS (ttm) | -2.12 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 354K USD |
| Total Cash Per Share (mrq) | 0.15 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 1.63 |
| Book Value Per Share (mrq) | 1.271 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -3128000 USD |
| Levered Free Cash Flow (ttm) | -2139625 USD |
Profile of Alaunos Therapeutics
| Country | United States |
| State | FL |
| City | Fort Lauderdale |
| Address | 501 E. Las Olas Blvd. |
| ZIP | 33301 |
| Phone | 346 355 4099 |
| Website | https://www.alaunos.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 1 |
Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. It develops non-hormonal, non-incretin approach, and unlike hormone-based treatments, such as GLP-1 drugs. The company also develops hunTR TCR discovery platform to target driver mutations. Alaunos Therapeutics, Inc. was founded in 2003 and is based in Fort Lauderdale, Florida.
Q&A For Alaunos Therapeutics Stock
What is a current TCRT stock price?
Alaunos Therapeutics TCRT stock price today per share is 2.62 USD.
How to purchase Alaunos Therapeutics stock?
You can buy TCRT shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Alaunos Therapeutics?
The stock symbol or ticker of Alaunos Therapeutics is TCRT.
Which industry does the Alaunos Therapeutics company belong to?
The Alaunos Therapeutics industry is Biotechnology.
How many shares does Alaunos Therapeutics have in circulation?
The max supply of Alaunos Therapeutics shares is 2.44M.
What is Alaunos Therapeutics Price to Earnings Ratio (PE Ratio)?
Alaunos Therapeutics PE Ratio is now.
What was Alaunos Therapeutics earnings per share over the trailing 12 months (TTM)?
Alaunos Therapeutics EPS is -2.12 USD over the trailing 12 months.
Which sector does the Alaunos Therapeutics company belong to?
The Alaunos Therapeutics sector is Healthcare.
Alaunos Therapeutics TCRT included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 26853.98 USD — |
-0.89
|
8.32B USD — | 26769.16 USD — | 27130.88 USD — | — - | 8.32B USD — |
| Stlmt ID US Tech Biotechnology NBX | 3995.9 USD — |
-4.37
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
| US Tech Global Select Market Com NQGS | 13180.97 USD — |
-0.87
|
— — | 13139.79 USD — | 13316.81 USD — | — - | — — |
| US Tech Biotechnology NBI | 5807.22 USD — |
+1.87
|
— — | 5685.34 USD — | 5809.82 USD — | — - | — — |
| US Tech Health Care IXHC | 1133.51 USD — |
+1.54
|
— — | 1113.35 USD — | 1133.95 USD — | — - | — — |
- {{ link.label }} {{link}}